Dual‐Specificity Phosphatase 9 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through ASK1 Suppression

Nonalcoholic fatty liver disease (NAFLD), ranging from nonalcoholic fatty liver to nonalcoholic steatohepatitis (NASH), is the leading cause of chronic liver diseases. Until now, no medications for NAFLD have been approved by relevant governmental agencies. Dual‐specificity phosphatase 9 (Dusp9) is...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Hepatology
Hoofdauteurs: Ye, Ping, Xiang, Mei, Liao, Hua, Liu, Jijun, Luo, Hongbo, Wang, Yayun, Huang, Ling, Chen, Manhua, Xia, Jiahong
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2018
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590435/
https://ncbi.nlm.nih.gov/pubmed/30063256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.30198
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items